Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins

被引:96
|
作者
Urso, ML
Clarkson, PM
Hittel, D
Hoffman, EP
Thompson, PD
机构
[1] Univ Massachusetts, Dept Exercise Sci, Amherst, MA 01003 USA
[2] Hartford Hosp, Div Cardiol, Henry Low Heart Ctr, Hartford, CT 06115 USA
[3] Childrens Natl Med Ctr, Res Ctr Genet Med, Washington, DC 20010 USA
关键词
D O I
10.1161/01.ATV.0000190608.28704.71
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Statins are safe medications but have side effects including myalgia and rhabdomyolysis. How statins provoke muscle damage is not known, but this effect is exacerbated by exercise. Methods and Results - Healthy subjects took Atorvastatin (80 mg/daily) or placebo for 4 weeks. Biopsies of both vastus lateralis muscles were performed 8 hours after eccentric exercise ( known to result in muscle soreness and damage) of the left leg at baseline and the right leg after statin/placebo treatment. Gene expression was determined using Affymetrix GeneChips, and selected genes confirmed by polymerase chain reaction (qRT-PCR). Atorvastatin had little effect on gene expression at rest. When combined with exercise, 56 genes were differentially expressed with 18% involved in the ubiquitin proteasome pathway (UPP) and 20% involved in protein folding and catabolism, and apoptosis. Conclusion - This is the first investigation to our knowledge to implicate involvement of the UPP in skeletal muscle in response to combined exercise and statin treatment, possibly explaining the onset of myalgia with exertion. Statins may alter the response of muscle to exercise stress by altering the action of the UPP, protein folding, and catabolism, disrupting the balance between protein degradation and repair.
引用
收藏
页码:2560 / 2566
页数:7
相关论文
共 50 条
  • [1] Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle
    Wray, CJ
    Sun, XY
    Gang, GI
    Hasselgren, PO
    JOURNAL OF SURGICAL RESEARCH, 2002, 104 (02) : 82 - 87
  • [2] Physical training attenuates gene expression of ubiquitin-proteasome pathway in diabetic mouse skeletal muscle
    Lehti, Maarit
    Silvennoinen, Mika
    Kiveli, Riikka
    Kainulainen, Heikki
    Komulainen, Jyrki
    FASEB JOURNAL, 2007, 21 (06): : A837 - A837
  • [3] Ubiquitin-proteasome pathway in skeletal muscle atrophy
    Pang, Xiangsheng
    Zhang, Peng
    Chen, Xiaoping
    Liu, Wenming
    FRONTIERS IN PHYSIOLOGY, 2023, 14
  • [4] Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients
    LLovera, M
    Garcia-Martinez, C
    Agell, N
    Lopez-Soriano, FJ
    Authier, FJ
    Gherardi, RK
    Argiles, JM
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 2 (01) : 69 - 73
  • [5] Effect of unweighting on the ubiquitin-proteasome pathway of skeletal muscle in rat
    Yimlamai, T
    Smith, I
    Payne, A
    Dodd, SL
    FASEB JOURNAL, 2002, 16 (05): : A770 - A770
  • [6] Response of the ubiquitin-proteasome pathway to changes in muscle activity
    Reid, MB
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 288 (06) : R1423 - R1431
  • [7] The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer
    Williams, A
    Sun, XY
    Fischer, JE
    Hasselgren, PO
    SURGERY, 1999, 126 (04) : 744 - 749
  • [8] Statins, Exercise, and Skeletal Muscle
    Kraus, William E.
    Patel, Mahesh J.
    EXERCISE AND SPORT SCIENCES REVIEWS, 2012, 40 (04): : 187 - 187
  • [9] Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia
    Chai, JK
    Wu, YQ
    Sheng, ZY
    CRITICAL CARE MEDICINE, 2003, 31 (06) : 1802 - 1807
  • [10] Contributions of the ubiquitin-proteasome pathway and apoptosis to skeletal muscle wasting with age
    Whitman, SA
    Wacker, MJ
    Richmond, SR
    Godard, MP
    FASEB JOURNAL, 2005, 19 (05): : A1575 - A1575